Shilpa Medicare Fixes October 3 as Record Date for 1:1 Bonus Issue

Bengaluru, September 29, 2025: Shilpa Medicare Limited has announced that it has fixed October 3 as the record date for its 1:1 bonus share. Record date is the date on which a company checks its shareholders’ list to determine eligible shareholders for the bonus issue. Hence, investors who want the benefit of Shilpa Medicare’s bonus issue must buy the shares on or before October 1 (as October 2 is a stock market holiday) to be eligible for the bonus issue.

Shilpa Medicare Limited is an Indian global pharmaceutical company. The company develops, manufactures, and markets Active Pharmaceutical Ingredients (APIs), finished dosage formulations, and novel drug delivery systems. It was established in 1987 and is headquartered in Raichur, Karnataka. The shares of the company are listed on NSE with the ticker symbol of SHILPAMED and on BSE with the code 530549.

The 1:1 bonus issue means that for every 1 share held by shareholders on the record date, they will receive one extra share. However, the investment value will remain the same as the share price of Shilpa Medicare will adjust to the bonus issue and fall by 50%. This will also double the company’s share capital and will potentially increase the liquidity.

Shares Rise By 0.65%

Following the announcement, Shilpa Medicare Limited’s share price was witnessing positive investor demand in the afternoon session. As of 12:40 PM, the shares were up by 0.65%, or 5.05 points, and were trading at ₹776.90. Until now, the shares have traded within a range of ₹783.90 and ₹756.55. The current traded volume stands at 45.11 thousand shares, with the company’s market cap at ₹7,548 crore.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations